Related Experiment Video
Updated: Jul 15, 2025

05:54
Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
Published on: September 5, 2018
8.6K
3D cell subculturing pillar dish for pharmacogenetic analysis and high-throughput screening
Sang-Yun Lee1,2, Hyun Ju Hwang1, You Jin Song3
1Central R & D Center, Medical & Bio Decision (MBD) Co., Ltd, Suwon, 16229, Republic of Korea.
Materials Today. Bio
|September 28, 2023
Summary
A novel pillar dish enables stable 3D cell culture on hydrogel spots, improving high-throughput screening. This method enhances lung cancer cell stemness and drug sensitivity, offering new therapeutic targets.
Area of Science:
- Biotechnology
- Cell Biology
- Cancer Research
Background:
- 3D cell culture in extracellular matrices (ECM) preserves cell properties, unlike 2D culture.
- Conventional 3D culture methods lack uniformity and stability.
- Pillars in a new dish design ensure consistent hydrogel spot shape and location for reproducible 3D cell culture.
Purpose of the Study:
- To develop a pillar dish for stable 3D cell subculture on hydrogel spots.
- To utilize this system for high-throughput screening (HTS) of lung cancer cells.
- To investigate the impact of 3D culture on cancer cell stemness and drug sensitivity.
Main Methods:
- Developed a pillar dish for 3D cell culture using Matrigel and alginate hydrogels.
- Subcultured A549 lung cancer cells over 6 passages in the pillar dish.
- Performed drug screening and differential gene expression analysis on 3D-cultured cells.
Main Results:
- Lung cancer cell growth rate was higher on Matrigel than alginate.
- 3D-subcultured cells showed upregulated stemness markers compared to 2D-cultured cells.
- Key cancer pathways (PI3K/Akt/mTOR, VEGFR, Wnt) were activated in 3D cultures, indicating drug sensitivity.
Conclusions:
- The pillar dish facilitates stable 3D cell culture and supports HTS.
- 3D culture enhances lung cancer cell stemness and drug resistance characteristics.
- Activated pathways in 3D cultures suggest potential therapeutic targets and improved drug screening efficacy.

